chrisvoncsefalvay/vaers-outcomes huggingface dataset:
convulsing; glossopharyngeal neuralgia; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old male patient received bnt162b2 (BNT162B2), on 07Mar2021 as dose 2, 0.3 ml single (Lot number: EN6199, Expiration Date: Jun2021) at the age of 70 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: bnt162b2 (Vaccine: 1st dose Covid-19, Product name/Manufacturer: Pfizer BioNTech, Exp: Jun2021, Lot# EM9810, 0.3 ml), administration date: 07Feb2021, when the patient was 70-year-old, for COVID-19 immunization. The following information was reported: SEIZURE (medically significant) with onset 2021, outcome "unknown", described as "convulsing"; GLOSSOPHARYNGEAL NEURALGIA (non-serious) with onset 2021, outcome "unknown". The events "convulsing" and "glossopharyngeal neuralgia" required physician office visit. Clinical course was as follow: the patient was vaccinated in Feb2021 and Mar2021. A month or so later he started having severe nerve pain in his head, ear and throat. These were events that happened daily once or twice lasting 2-3 minutes - severe pain, coughing, gagging and convulsing. This continued for several months then stopped for a short time. When it started up again he went to his doctor who could not figure it out. He then went to a ear - nose and throat doctor who could not figure it out and ordered a swallowing test and an MRI. The patient had suggested it might be a rare condition call Glassopharngeal neuralgia. Initially the doctor said he doubted it because it was so rare but after the tests he said - maybe. The doctor referred him to a neurologist. At this point he could not even talk as talking would trigger these events and would swallowing etc. The neurologist tested him causing an attack and agreed that it was Glassopharnegeal neuralgia - a very rare condition. When asked if this could be Covid vaccine related he stated "very possibly". He advised the patient not to get any boosters which he had not. The neurologist put the patient on a heavy dose of Gabapentin which he was on for two years. This eventually controlled the convulsions/attacks. Just recently the patient weaned off of the medicine and not having any more attacks.
About 3 hours after shot I got diarrhea and it was bad. Pain in arm, dizziness and loss taste and i have not gotten back yet, joint pain, tiredness, fever. I have been so thirsty i have been drinking a ton of water.   i had all the symptoms of covid .  I had covid in November and symptoms were worse .
So when I woke the next morning I was basically feeling like I had an auto immune flare, my neuropathy was on fire, headache, tired, exhausted, I basically felt really tired all day. The next day I felt a little bit better and went to work but around noon I felt nauseated and all the symptoms returned and they stayed that way until I contacted my rheumatologist. They prescribed me prednisone on the 21st. On the 22nd I felt a little better. On the 23rd I felt good. On the 24th as I was tapering off of the prednisone the symptoms started returning. Then I met with MD and she told me to continue with the prednisone at 5mg and also hydroxyzine for my nausea and an antihistamine. The nausea was the biggest symptom after the prednisone and I could not eat anything. Even 2 pieces of toast I would get nauseated, not throw up but severely nauseated. I could drink anything but not eat and it stayed like that for a long time. Went on a bland diet and with the visterol I could eat more and better and no just mild nausea and exhaustion, I am still pretty fatigued and my joint pain is still bothering me but not as much as the beginning. Also dizziness.
12/09/2021: pt admitted 10 days after COVID symptoms. Received medrol dose-pak and monoclonal antibody as outpatient before admission. Presented due to worsening O2 requirements at home. 12/10-12/11: symptoms improved. Discharged after observation on  Decadron.
Patient received vaccine and proceeded to observation area. While patient was sitting she had a brief episode of syncope but quickly regained consciousness. Patient was place on the floor to lay down and given juice. She stated that she felt much better almost right away. We observed her for 20-30 minutes until the patient felt well enough to leave on her own.
Acute CVA occurred on 3/29/21. Patient expressed concerns to PCP that vaccine could have caused stroke.
Redness, swelling, and hot at injection site along with left cheek redness at approximately 7:00 pm each evening.
I was around 5/6 weeks when I got the shot. I started bleeding at work, went to ER, there was no heartbeat. Lost baby according to ultrasound at 6w3d. Est due date was Feb 15, 2022.
Patient came to pharmacy on 11/1/10 & 11/2/10 complaining of muscle tightness, weakness, lack of appetite, muscle pain & back pain. States she thinks its a result of flu shot given on 10/25.
Swollen, red/ tender, raised area about 5 inches in diameter instructed to use: Benadryl, antiinflammatories, et to call this office of condition worsened.
Severe pain in arm; Feverish; Tired; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 62-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm, fever and tiredness. On an unknown date, the outcome of the pain in arm, fever and tiredness were unknown.   It was unknown if the reporter considered the pain in arm, fever and tiredness to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported. The patient experienced severe pain in my arm, feverish and tired after vaccination. The patient asked how long should expect to experience some of the side effects to shingrix.
feeling weak; cough; nausea; Soreness of the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (feeling weak), COUGH (cough), NAUSEA (nausea) and VACCINATION SITE PAIN (Soreness of the injection site) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.  On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (feeling weak), COUGH (cough), NAUSEA (nausea) and VACCINATION SITE PAIN (Soreness of the injection site). At the time of the report, ASTHENIA (feeling weak), COUGH (cough), NAUSEA (nausea) and VACCINATION SITE PAIN (Soreness of the injection site) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitant medication was reported.  It was not reported if the patient was received any corrective treatment for the event.
BLOOD CLOT FROM NOSE; TEMPORARILY UNABLE TO WALK, RICKETY KNEES; BURNING LEG PAIN; JOINT PAIN/ SHOULDER PAIN; SHOULDER FEEL TIGHT; This spontaneous report received from a patient concerned a 30 year old  male. The patient's height, and weight were not reported. The patient's concurrent conditions included cigarette smoker (occasional pot; rarely). The patient's grandfather died from blot clot under knee (thrombosis). The patient had no history of bloody nose.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: UNKNOWN) dose was not reported, administered on left arm on 28-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 30-MAR-2021 (two days after vaccination) the patient experienced really bad burning leg pain for few days and his joints in shoulder and knees were affected two days after vaccination and he could not walk (temporarily unable to walk). The patient also experienced rickety knees. On the same day, the patient blew out a huge blood clot from his nose. On 2021, the patient's shoulder felt tight. At the time of this report, the patient's knees and shoulders were still feeling tight like there was hardly any cartilage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from blood clot from nose, and temporarily unable to walk, rickety knees, was recovering from joint pain/ shoulder pain, and the outcome of burning leg pain and shoulder feel tight was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-Covid-19 vaccine ad26.cov2.s-blood clot from nose. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY
Subsequent to receiving one dose of varicella virus vaccine live the pt experienced chickenpox in the sub mental region. Pt also experienced cellulitis. The pt was hospitalized and was administered antibiotics. Cultures were preformed for strep group A.
A 55 year old female patient (DO) experienced fever, chills, nausea, lethargy, night sweats and injection site tenderness after receiving RabAvert for post-exposure treatment. The patient has no significant medical history and is not taking any medication. She was exposed to a bat while sleeping on 06/22/2004. She received RabAvert on day three on 06/25/2004 and experienced fever, chills, nausea, lethargy and head to toe drenching night sweats that same day. She had received Imovax for her first dose, then received RabAvert 1 ml injection into her deltoid for her second dose of post exposure treatment. The symptoms had resolved by 06/25/2004 and she went in for her day seven injection the following day. Six hours post day seven injection on 06/29/2004 the patient reported tenderness at injection site in addition to another episode of drenching head to toe night sweats.
On the 2nd day after the 4th Covid bivalent booster vaccine, my husband had a full syncope. It happened shortly after lunch. He passed out while standing on the kitchen counter to take his daily vitamins. He regained consciousness 30 sec after.
I got the vaccine at 9am. At 4pm that same day I experienced terrible pain to left arm. No redness or swelling at the site. I couldnt lie on my left arm at all that night.  By 11pm I also experienced headache, sinus drainage, sore throat, body aches, taste and smell were off, upset stomach, queezy stomach but no nausea or vomiting, very weak , dry mouth, fever at 99.2 then 98.6, chills, lots of chills. The covid hotline at my work told me I had a moderate reaction to the vaccine. Treatment was rest and tylenol which didn't alleviate any symptoms whatsoever. I had all these symptoms til Jan 6th at 4am.   At 4am all the symptoms left and have not returned.
This spontaneous report was received from a healthcare worker and refers to unspecified number patients of unknown age and gender. No information about patients' pertinent medical history, concurrent conditions, concomitant medications, drug reactions or allergies was provided. On unspecified dates, the patients were administered doses of MMR II (lot # K015374, expiration date 18-SEP-2016 and lot# K007108, expiration date 16-MAY-2016) and MMR II albumin status unknown (lot/batch # reported as K005100 (not valid for MMR II), expiration date 04-APR-2016 (dose and route of administration were not reported) which were exposed to temperatures outside of the recommended range. No adverse experience was reported. This is one of several reports from the same reporter. Additional information has been requested.
TEMP: 97.1 2 DAYS INCREASING ERYTHEMA; INDURATION SURROUNDING INJECTION SITE RIGHT ARM, DIFFUSE PRURITIS, NO RESPIRATORY COMPROMISE.  SMALL AREA INDURATION ALSO PRESENT ON R HIP. TREATED WITH PREDNISOLONE 15/5, 2/3 TSP BID X5 DAYS. ORAL BENADRYL. CEPHALEXIN 250/5, 1 TSP Q8H X 7 DAYS.
tested positive for COVID/COVID-19 confirmed by positive COVID-19 test/sore throat and cold symptoms a day before/ fever for days/ has a mild cough and mild mucus after he eats; COVID-19 confirmed by positive COVID-19 test/sore throat and cold symptoms a day before/ fever for days/ has a mild cough and mild mucus after he eats; mild mucus after he eats; This is a spontaneous report from a contactable consumer (Patient) reported that a male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration on 27Jan2021 as single dose, for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took bnt162b2 for Covid-19 immunisation (Dose 1). It was reported that caller mentioned that he already received 2 doses of the Pfizer COVID19 Vaccine and had received his seconnd dose on 27Jan2021. He tested positive for COVID Last Monday after experiencing sore throat and cold symptoms a day before. He had a fever for days which went away. He still has a mild cough and mild mucus after he eats on 2021. He was asking for what to do. The patient underwent lab tests and procedures which included sars-cov-2 test: was positive on 2021. The outcome of the event mild mucus after he eats was not recovered and other events was unknown.   Information about Lot/Batch number has been requested.
Sore arm; tiredness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Oct2022 as dose 5 (booster), single (Lot number: 6J6665) at the age of 64 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Minimal allergy to peanuts" (unspecified if ongoing), notes: Known allergies: Minimal allergy to peanuts; Other medical history were none. The patient's concomitant medications were not reported. Vaccination history included: moderna (DOSE 4 (BOOSTER), SINGLE, vaccine lot number: 954A22A, vaccine location: Left arm), administration date: 06Jul2022, when the patient was 64-year-old, for COVID-19 Immunization; moderna (DOSE 3 (BOOSTER), SINGLE, vaccine lot number: 012H21B, vaccine location: Left arm), administration date: 03Dec2021, when the patient was 64-year-old, for COVID-19 Immunization; moderna (DOSE 2, SINGLE, vaccine lot number: 021C21A, vaccine location: Left arm), administration date: 29Apr2021, when the patient was 63-year-old, for COVID-19 Immunization; moderna (DOSE 1, SINGLE, vaccine lot number: 030B21A, vaccine location: Left arm), administration date: 31Mar2021, when the patient was 63-year-old, for COVID-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "Sore arm"; FATIGUE (non-serious), outcome "recovered", described as "tiredness". Therapeutic measures were not taken as a result of pain in extremity, fatigue.  Additional information: The patient had sore arm and last vaccination (Pfizer bivalent) caused tiredness.
A very strong pain around the shot spot on my arm. It was a lot more than the first shot. I could not sleep comfortably at night because of it. Interestingly, that was the only adverse effect I had and I was expecting more because everybody on line said the second shot side effects were to be more serious than the first one. I am glad sore arm was the only thing I experienced. I took Ibuprofen for it and it helped a little but did not do away with the pain completely. When I woke up the second day after the shot, the pain was almost completely gone.
.  I became extremely drowsy, to the point of putting my car windows down, not realizing at that time it was due to vaccine, also quite anxious for no reason.  At home, ate, lay down, woke up 12 hrs. later to severe H/A, progressed to N/V, severe aches and a terrible rash on my head, face, torso.  I developed pressure, tightness in my chest, as if I had asthma.  I could not walk up a flight of stairs for 2 weeks without feeling SOB.  I had a COVID test due to being concerned, but had received much info. regardng the second dose, so thought this was normal.  I finally, though, used an inhaler several times and did feel better.  I, however, do not feel back to normal as far as mood, energy.  Will never have it again.
Diarrhea for 8-10 hours, then clear effluent for 6 hours.  Diarrhea starting again after second shot in series.
Patient was administered the MMR, varicella, and flu vaccines on Jan 6. On Jan 12, 6 days later he experienced mild to high fevers, red swollen cheeks, lost of appetite, scream crying. Day 10 he developed a rash on one of the injection sites and a rash all over the body chest, back, legs, face.
RASH /RASH SPREAD EVERYWHERE; This spontaneous report received from a patient concerned a 34 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982, and expiry: 21-SEP-2021) dose was not reported, administered on 07-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-SEP-2021, the patient experienced rash /rash spread everywhere. Treatment medications (dates unspecified) included: triamcinolone. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from rash /rash spread everywhere. This report was non-serious.
6-13-11 15x25 red, slightly tender, slightly firm patch (L) upper ant. thigh with central dark purple area - injection site of DTAP. Given DURICEF 250/5 1 tsp BID for leg cellulitis.
Patient is a 97 y.o. female with history of CAD, prior CABG, aortic stenosis, GERD, COPD, CHF, HTN, HLD, recent TAVR, presented to Medical Center as a transfer from Adena with shortness of breath in the setting of recent TAVR, and current COVID infection.  Treated with oxygen, paxlovid, azithromycin.  Weaned to room air.  Discharged to SNF.   Covid-19 Virus Infection Date of onset of symptoms: 12/10 Symptoms present on admission: Cough, SOB, Date of covid positive test: 12/12 Vaccination status: vaccinated Imaging: CXR (12/12) nonacute; CTA chest (12/12) bilateral tree-in-bud nodules, infectious bronchiolitis, stable bronchiectasis and consolidation in RML Oxygen requirements on admission: Room air Current oxygen requirements: Room air as of 12/19 Medical therapy:  -Decadron started 12/17 given patient now requiring O2  ID cs'd to assess eligibility for additional covid treatment- paxlovid, zithromax added 12/18 Anticipated special isolation end date: 12/22 , and will be able to trasnport to SNF/rehab on that date Weaned to room air and ready for D/c   Acute Hypoxemic Respiratory Failure - resolved Etiology: covid Baseline O2 requirements: room air Current O2 requirements: room air Continue pulmonary hygiene- IS q 1hr Continue treatment of underlying etiologies as outlined   History of TAVR CAD Chronic HFpEF Clinically euvolemic, no chest pain or shortness of breath at this time Underwent TAVR at GMC on 12/9 Although patient presented to OLH, suspect secondary to COVID infection BNP at OLH was less than her baseline Troponin was elevated but flat at OLH Patient might benefit from echocardiogram given her recent TAVR, however this does not seem urgent at this time Defer cardiology consultation for now Resume home aspirin, statin, Plavix, Cardizem, Lasix, lisinopril   Acute on Chronic Anemia Baseline Hgb 8-10 No evidence of active bleeding Hgb 8.2 12/16 Iron studies WNL  HTN Well-controlled Resume home antihypertensives   HLD Continue statin   COPD without exacerbation Not in acute exacerbation On chronic prednisone, continue at discharge Continue controller meds, Albuterol as needed   Bilateral lower extremity wounds Bilateral lower extremity wounds present on admission, reportedly traumatic  Not actively infected Wound care consulted and following
Discomfort caused by moderate swelling of the axillary lymph nodes in the same arm as injection was given as well as soreness at the injection site. Swelling has lasted 4 days thus far.
sensation or sensitivity of the tenderness where he had shingles before, on the left side, left abdomen area; This is a spontaneous report received from contactable reporter (consumer, patient's wife).  A 75 year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), administered in arm left, administration date 04Mar2021 at 10:15 (Batch/Lot number and Expiration date: unknown) at the age of 75 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Thyroid disorder" (unspecified if ongoing); "shingles", start date: 2019 (unspecified if ongoing). The patient took concomitant medications. There were no additional vaccines administered on same date of the Pfizer vaccine. The patient had no prior vaccinations (within 4 weeks) and no adverse events. The patient has no family medical history relevant to the event. The following information was reported: HYPERAESTHESIA (non-serious) with onset 05Mar2021, outcome "recovered" (06Mar2021), described as "sensation or sensitivity of the tenderness where he had shingles before, on the left side, left abdomen area ". Course of event: Patient's wife stated that her husband had a reaction from the vaccine that started on 05Mar2021. She stated that he had shingles 2 years ago. After the shot, he had the sensation or sensitivity of the tenderness where he had shingles before, on the left side, left abdomen area and it was gone by 06Mar2021. The event started in the evening. Reporter stated that the patient takes thyroid medication, but it doesn't have to do with this, no details provided. The event did not require a visit to the Emergency Room and physician office. The patient had no relevant tests.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Immediately following the administration of 4th vaccine, client slumped over in chair, appeared to experience a seizure and was incontinent of urine.  Episode lasted approximately 30-45 seconds.  No apparent LOC. No SOB or respiratory distress noted.  Cold compress applied to neck. EMS arrived and client agreed to transport to local hospital for further evaluation.03/06/07-records received from facility for DOS 02/08/07-DX Syncope. Denies fall or injury-evaluated in ER and discharged. No diagnostics ordered.
Subsequently post vax, the pt developed swelling at the injection site that extended from his shoulder to his elbow.
extreme skin sensitivity in a few areas: pants waistband on the right side chafed, resulting in rash and blisters
At 3 months post second COVID-19 vaccine (Moderna), developed onset of intermittent left sided chest pain, syncopal episodes, intermittent vertigo, intermittent SOB, and lethargy.  All symptoms can be exertional or non-exertional.  Have underwent inpatient hospitalization for the above and undergone multiple testing.   Have had a CT of the chest, CXR, echocardiogram, cardiac stress testing (chemical), EKGs, multiple labs, and heart catheterization.   All testing has been essentially normal including ruling out inflammatory process.